Lee, Clare J.

Efficacy and safety of a novel dual GIP and GLP-1 receptor agonist tirzepatide in patients with type 2 diabetes (SURPASS-1): a double-blind, randomised, phase 3 trial

Rosenstock, J., Wysham, C., Frías, J. P., Kaneko, S., Lee, C. J., Fernández Landó, L., Mao, H., Cui, X., Karanikas, C. A., & Thieu, V. T. (2021) · The Lancet

Diabetes Treatment and ManagementDiabetes Management and Research

Cited by 1,080

Tirzepatide as Compared with Semaglutide for the Treatment of Obesity

Aronne, L. J., Horn, D. B., le Roux, C. W., Ho, W., Falcon, B. L., Gomez Valderas, E., Das, S., Lee, C. J., Glass, L. C., Senyucel, C., et al. (2025) · New England Journal of Medicine

Pharmacology and Obesity TreatmentDiabetes Treatment and Management

Cited by 634

Efficacy of Commercial Weight-Loss Programs: An Updated Systematic Review

Gudzune, K. A., Doshi, R. S., Mehta, A. K., Chaudhry, Z. W., Jacobs, D. K., Vakil, R. M., Lee, C. J., Bleich, S. N., & Clark, J. M. (2015) · Annals of Internal Medicine

Pharmacology and Obesity TreatmentObesity, Physical Activity, Diet

Cited by 325

The association of severe hypoglycemia with incident cardiovascular events and mortality in adults with type 2 diabetes

Lee, A. K., Warren, B., Lee, C. J., McEvoy, J. W., Matsushita, K., Huang, E. S., Sharrett, A. R., Coresh, J., & Selvin, E. (2018) · Diabetes Care

Diabetes Management and ResearchDiabetes Treatment and Management

Cited by 226

Prevalence of and risk factors for hypoglycemic symptoms after gastric bypass and sleeve gastrectomy: Postsurgical Hypoglycemic Symptoms

Lee, C. J., Clark, J. M., Schweitzer, M., Magnuson, T., Steele, K., Koerner, O., & Brown, T. T. (2015) · Obesity

Bariatric Surgery and OutcomesMinimally Invasive Surgical Techniques

Cited by 159

Risk factors for severe hypoglycemia in black and white adults with diabetes: the Atherosclerosis Risk in Communities (ARIC) study

Lee, A. K., Lee, C. J., Huang, E. S., Sharrett, A. R., Coresh, J., & Selvin, E. (2017) · Diabetes Care

Diabetes Management and ResearchDiabetes Treatment and Management

Cited by 119

Severe hypoglycaemia, mild cognitive impairment, dementia and brain volumes in older adults with type 2 diabetes: the Atherosclerosis Risk in Communities (ARIC) cohort study

Lee, A. K., Rawlings, A. M., Lee, C. J., Gross, A. L., Huang, E. S., Sharrett, A. R., Coresh, J., & Selvin, E. (2018) · Diabetologia

Dementia and Cognitive Impairment ResearchDiabetes Management and Research

Cited by 115

Hormonal Response to a Mixed-Meal Challenge After Reversal of Gastric Bypass for Hypoglycemia

Lee, C. J., Brown, T., Magnuson, T. H., Egan, J. M., Carlson, O., & Elahi, D. (2013) · The Journal of Clinical Endocrinology & Metabolism

Bariatric Surgery and OutcomesMinimally Invasive Surgical Techniques

Cited by 65

Predictors of ≥15% weight reduction and associated changes in cardiometabolic risk factors with tirzepatide in adults with type 2 diabetes in SURPASS 1-4

Małecki, M. T., Batterham, R. L., Sattar, N., Levine, J. A., Rodríguez, Á., Bergman, B. K., Wang, H., Ghimpeteanu, G., & Lee, C. J. (2023) · Diabetes Care

Diabetes Treatment and ManagementPharmacology and Obesity Treatment

Cited by 52

Cardiometabolic Parameter Change by Weight Regain on Tirzepatide Withdrawal in Adults With Obesity: A Post Hoc Analysis of the SURMOUNT-4 Trial

Horn, D. B., Linetzky, B., Davies, M. J., Laffin, L. J., Wang, H., Murphy, M. A., Zimner-Rapuch, S., Lau, E., Arad, A. D., & Lee, C. J. (2026) · JAMA Internal Medicine

Pharmacology and Obesity TreatmentDiabetes Treatment and Management

Cited by 50

The incidence and risk factors associated with developing symptoms of hypoglycemia after bariatric surgery

Lee, C. J., Brown, T. T., Schweitzer, M., Magnuson, T., & Clark, J. M. (2018) · Surgery for Obesity and Related Diseases

Bariatric Surgery and OutcomesDiabetes Management and Research

Cited by 49

Tirzepatide as monotherapy improved markers of beta-cell function and insulin sensitivity in type 2 diabetes (SURPASS-1).

Lee, C. J., Mao, H., Thieu, V. T., Landó, L. F., & Thomas, M. K. (2023) · Journal of the Endocrine Society

Diabetes Treatment and ManagementDiabetes Management and Research

Cited by 47

Levothyroxine dosing following bariatric surgery

Gadiraju, S., Lee, C. J., & Cooper, D. S. (2016) · Obesity Surgery

Bariatric Surgery and OutcomesThyroid Disorders and Treatments

Cited by 39

Tirzepatide and the 10‐year predicted risk of cardiovascular disease and type 2 diabetes in adults with obesity and prediabetes: A post hoc analysis from the three‐year SURMOUNT ‐1 trial

Hankosky, E. R., Lebrec, J., Lee, C. J., Dimitriadis, G. K., Jouravskaya, I., Stefanski, A., & Garvey, W. T. (2025) · Diabetes, Obesity and Metabolism

Diabetes Treatment and ManagementPharmacology and Obesity Treatment

Cited by 17

A systematic review of commercial weight loss programmes’ effect on glycemic outcomes among overweight and obese adults with and without type 2 diabetes mellitus

Chaudhry, Z. W., Doshi, R. S., Mehta, A. K., Jacobs, D. K., Vakil, R. M., Lee, C. J., Bleich, S. N., Kalyani, R. R., Clark, J. M., & Gudzune, K. A. (2016) · Obesity Reviews

Diabetes, Cardiovascular Risks, and LipoproteinsBariatric Surgery and Outcomes

Cited by 16

Comparative Effects of Medical Versus Surgical Weight Loss on Body Composition: a Pilot Randomized Trial

Varma, S., Lee, C. J., Brown, T. T., Maruthur, N. M., Schweitzer, M., Magnuson, T., Kamel, I., & Clark, J. M. (2019) · Obesity Surgery

Bariatric Surgery and OutcomesBody Contouring and Surgery

Cited by 10

337-OR: Tirzepatide Improved Markers of Islet-Cell Function (Fasting Glucagon and HOMA2-B) and Insulin Sensitivity (Fasting Insulin and HOMA2-IR) Compared with Semaglutide in People with Type 2 Diabetes

BROWN, K., LANDO, L. F., BERGMAN, B., THOMAS, M. K., LIU, B., & LEE, C. (2022) · Diabetes

Diabetes Treatment and ManagementDiabetes Management and Research

Cited by 4